Likewise, in breast cancer, downregulation of LINC00518 impedes Wnt signaling activation, thereby restraining the expression of EMT-associated proteins Slug, Snail1, Twist1, ZEB1, and ZEB2, while promoting E-cadherin expression (37). Here, LINC00518 is linked to breast carcinoma.